These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The inheritance of progressive muscular dystrophy in Japan. Murakami U Jinrui Idengaku Zasshi; 1967 Dec; 12(3):150-69. PubMed ID: 5626875 [No Abstract] [Full Text] [Related]
23. Studies on progressive muscular dystrophy. II. Relation between clinical effect of adenosinetriphosphate on progressive muscular dystrophy and phosphate compounds in the muscle. Nakahara M Arzneimittelforschung; 1965 Jul; 15(7):782-5. PubMed ID: 5898681 [No Abstract] [Full Text] [Related]
25. A family of progressive muscular dystrophy with mental retardation. Clinical observations. Suga M; Yoshimuta S; Hayashi Y; Sakamoto F Jinrui Idengaku Zasshi; 1966 Mar; 10(4):189-92. PubMed ID: 6008646 [No Abstract] [Full Text] [Related]
26. [On the therapy of muscular diseases]. Mittelbach F; Bodechtel G Munch Med Wochenschr; 1968 Sep; 110(36):1988-93. PubMed ID: 5695705 [No Abstract] [Full Text] [Related]
27. [Therapeutic possibilities in myopathies, specifically in progressive muscular dystrophy]. Beckmann R Arch Kinderheilkd; 1965 Nov; 173(2):109-34. PubMed ID: 5329080 [No Abstract] [Full Text] [Related]
28. [Long term observations in muscular dystrophy. Therapeutic influence of disease course in progressive muscular dystrophy (8 long term observations)]. Schlenska GK; Kleine TO Med Welt; 1980 Jun; 31(25):940-4. PubMed ID: 6775171 [No Abstract] [Full Text] [Related]
29. Acanthosis nigricans following diethylstilbestrol therapy. Occurrence in patients with childhood muscular dystrophy. Banuchi SR; Cohen L; Lorincz AL; Morgan J Arch Dermatol; 1974 Apr; 109(4):545-6. PubMed ID: 4819110 [No Abstract] [Full Text] [Related]
30. [Heredity of myopathy, with special reference to progressive muscular dystrophy]. Sugita H Naika; 1970 Apr; 25(4):611-9. PubMed ID: 4912548 [No Abstract] [Full Text] [Related]
32. An approach to treatment trials in muscular dystrophy with particular reference to agents influencing free radical damage. Edwards RH; Jones DA; Jackson MJ Med Biol; 1984; 62(2):143-7. PubMed ID: 6471933 [No Abstract] [Full Text] [Related]
33. [On the current treatment of progressive muscular dystrophies in children]. Edel'shteĭn EA Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):173-7. PubMed ID: 4385315 [No Abstract] [Full Text] [Related]
34. [Results of insulin-glucose treatment in progressive muscular dystrophy]. Cerwenka W Beitr Orthop Traumatol; 1969 Nov; 16(11):656-61. PubMed ID: 5405859 [No Abstract] [Full Text] [Related]
35. [New aspects of the management of progressive muscular dystrophy]. Tilscher H; Schenk S Wien Med Wochenschr; 1967 Nov; 117(44):1000-2. PubMed ID: 5591872 [No Abstract] [Full Text] [Related]
36. Epidemiology of muscular dystrophies in northeast Tuscany. Pizzi A; Bellini F; Marconi G Acta Neurol (Napoli); 1988 Feb; 10(1 |||||||||||||):7-15. PubMed ID: 3254679 [No Abstract] [Full Text] [Related]
37. Hydrocortisone and/or desiccated thyroid in physiologic dosage. XIX. Muscular dystrophy: creatine phosphokinase during thyroid and alpha-tocopheryl acetate therapy. Vester JW; Balcerzak SP; Narduzzi JV; Danowski TS Metabolism; 1966 Nov; 15(11):971-9. PubMed ID: 4162451 [No Abstract] [Full Text] [Related]
38. [Genetics of progressive muscle dystrophy]. Sugita H Naika; 1969 Apr; 23(4):670-7. PubMed ID: 4895375 [No Abstract] [Full Text] [Related]
39. [Combined use of anabolic steroids and digitoxin in progressive muscular dystrophy]. Yamamoto H; Sugita H; Furukawa T Iryo; 1966 Jul; 20(7):704-8. PubMed ID: 5981771 [No Abstract] [Full Text] [Related]
40. [Muscular dystrophies in childhood. II: Follow-up studies in current therapy]. John R; Hässler A; Daute KH; John K Kinderarztl Prax; 1981 Feb; 49(2):71-81. PubMed ID: 7230622 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]